Showing results (1-10 of 44) with videos related to
Sort By:
Pageof 5
Lupus|February 9, 2016
Endometriosis and systemic lupus erythematosus: a population-based case-control studyH R Harris, J F Simard, E V ArkemaLupus|February 13, 2015
Perinatal risk factors for future SLE: a population-based nested case-control studyE V Arkema, J F SimardScandinavian Journal of Rheumatology|April 12, 2024
Sick leave and disability pension following delivery in women with systemic lupus erythematosusD Grannas, J F Simard, E Svenungsson, et al.Annals of the Rheumatic Diseases|November 29, 2013
Drug survival on TNF inhibitors in patients with rheumatoid arthritis comparison of adalimumab, etanercept and infliximabM Neovius, E V Arkema, H Olsson, et al.Clinical and Experimental Rheumatology|November 4, 2014
The Swedish Rheumatology Quality Register: optimisation of rheumatic disease assessments using register-enriched dataJ K Eriksson, J Askling, E V ArkemaAnnals of the Rheumatic Diseases|April 28, 2010
Efficacy of initial methotrexate monotherapy versus combination therapy with a biological agent in early rheumatoid arthritis: a meta-analysis of clinical and radiographic remissionB Kuriya, E V Arkema, V P Bykerk, et al.International Journal of Clinical Practice|June 20, 2007
What can epidemiology tell us about systemic lupus erythematosus?J F Simard, K H CostenbaderArthritis and Rheumatism|September 10, 2010
Juvenile idiopathic arthritis and risk of cancer: a nationwide cohort studyJ F Simard, M Neovius, S Hagelberg, et al.Annals of the Rheumatic Diseases|April 27, 2011
Sick leave and disability pension before and after initiation of antirheumatic therapies in clinical practiceM Neovius, J F Simard, L Klareskog, et al.Annals of the Rheumatic Diseases|December 13, 2005
Evidence for differential acquired drug resistance to anti-tumour necrosis factor agents in rheumatoid arthritisA Finckh, J F Simard, C Gabay, et al.Pageof 5